From Wikipedia, the free encyclopedia
Pharmaceutical compound
1F-LSD Other names 1-Formyl-LSD; 1-Formyl-N ,N -diethyllysergamide; N ,N -Diethyl-1-formyl-6-methyl-9,10-didehydroergoline-8β-carboxamide Routes of administration Oral ; Sublingual Drug class Serotonergic psychedelic ; Hallucinogen ATC code
N ,N -Diethyl-1-formyl-6-methyl-9,10-didehydroergoline-8β-carboxamide
Formula C 21 H 25 N 3 O 2 Molar mass 351.450 g·mol−1 3D model (JSmol )
CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C=O)CC
InChI=1S/C21H25N3O2/c1-4-23(5-2)21(26)15-9-17-16-7-6-8-18-20(16)14(12-24(18)13-25)10-19(17)22(3)11-15/h6-9,12-13,15,19H,4-5,10-11H2,1-3H3/t15-,19-/m1/s1
Key:SSEPNHFOVYUBHO-DNVCBOLYSA-N
1F-LSD , or 1-formyl-LSD , also known as 1-formyl-N ,N -diethyllysergamide , is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[ 1] [ 2] It is the 1-formyl derivative of LSD.[ 1] [ 2] [ 3]
The drug is assumed to act as a prodrug of LSD.[ 1] It produces psychedelic effects in humans similarly to LSD.[ 2] Effective doses have been reported to be 100 to 150 μg orally or sublingually .[ 2] Very little is known about the pharmacology and properties of 1F-LSD.[ 1]
1F-LSD was first described in the scientific literature by 2021.[ 2] It first emerged as a novel designer drug online in January 2019.[ 1] [ 2]
Another compound, 1‐(furan‐2‐carbonyl)‐LSD (SYN-L-005), has also been referred to as "1F-LSD".[ 3]
^ a b c d e "1F-LSD" . АИПСИН (in Russian). Retrieved 26 July 2025 .
^ a b c d e f Catalani, Valeria; Arillotta, Davide; Corkery, John Martin; Guirguis, Amira; Vento, Alessandro; Schifano, Fabrizio (9 February 2021). "Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach" . Frontiers in Psychiatry . 11 . doi :10.3389/fpsyt.2020.632405 . ISSN 1664-0640 .
^ a b Brandt, Simon D.; Kavanagh, Pierce V.; Gare, Sarah; Elliott, Simon P.; Stratford, Alexander; Halberstadt, Adam L. (3 December 2024). "Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD)" . Drug Testing and Analysis . doi :10.1002/dta.3829 . ISSN 1942-7603 .
No ring subs. 4-Hydroxytryptamines 5-Hydroxytryptamines 5-Methoxytryptamines Other ring subs.
2,N ,N -TMT
4,N ,N -TMT
5-Bromo-DMT
5-Chloro-DMT
5-Fluoro-DMT
5-N ,N -TMT
7,N ,N -TMT
5-MeO-2,N ,N -TMT
5-MeO-4,N ,N -TMT
6-Fluoro-DMT
Bretisilocin (GM-2505; 5-fluoro-MET)
α-Alkyltryptamines
5-Methoxy-α-alkyltryptamines: 5-MeO-AET
α,N ,N -TMT (α-Me-DMT; Alpha-N)
5-MeO-AMT (α,O -DMS; Alpha-O)
α,N ,O -TMS (5-MeO-α,N -DMT)
α,N ,N ,O -TeMS (5-MeO-α,N ,N -TMT)
Others
Ergolines /lysergamides (e.g., LSD )
β-Carbolines and Harmala alkaloids (e.g., harmine , harmaline , 6-methoxyharmalan )
Iboga alkaloids (e.g., 18-MAC , 18-MC , coronaridine , ibogaine , ibogamine , ME-18-MC , noribogaine , tabernanthine , voacangine )
Ibogalogs (e.g., ibogainalog )
O -Methylnordehydrobufotenine
Partial ergolines (e.g., NDTDI , RU-28306 , CT-5252 )
Piperidinylethylindoles (e.g., Pip-T )
Pyrrolidinylethylindoles (e.g., Pyr-T , 5-MeO-pyr-T )
Pyrrolidinylmethylindoles (e.g., MPMI , 4-HO-MPMI (lucigenol) , 5-MeO-MPMI )
Benzofurans (e.g., 5-MeO-DiBF , dimemebfe (5-MeO-BFE) , mebfap )
Benzothiophenes (e.g., 3-APBT )
Indazoles (e.g., AL-38022A , O -methyl-AL-34662 )
Indenes (e.g., C-DMT )
Isotryptamines (e.g., 6-MeO-isoDMT , Ro60-0175 )
MYCO-005
Quinolinylethylamines (e.g., mefloquine )
Others: 2C-G-x (e.g., 2C-G-3 , 2C-G-5 )
β-Keto-2C-B (βk-2C-B)
β-Keto-2C-I (βk-2C-I)
β-Methyl-2C-B (BMB)
(e.g., BOB , BOD , BOH-2C-B )
(e.g., HOT-2 , HOT-7 , HOT-17 )
N -Ethyl-2C-B
(e.g., 2CD-2-ETO , 2CD-5-ETO , 2CE-5-ETO , 2CE-5iPrO , 2CT2-5-ETO , ASR-2001 (2CB-5PrO) )
Others
2-TOET
2-TOM
25B-NAcPip
4-HA
5-TOET
5-TOM
Benzofurans (e.g., 5-APB , 5-APDB , 6-APB , 6-APDB , F , F-2 , F-22 )
Benzothiophenes (e.g., 5-APBT , 6-APBT )
CT-5172
DMAs (e.g., 2,4-DMA , 3,4-DMA )
Fenfluramine
MMA (3-MeO-4-MA)
Norfenfluramine
(e.g., 25D-NM-NDEAOP , DOB-NDEPA , DOI-NDEPA , DOM-NDEPA , DOTFM-NDEPA , M-NDEPA , TMA-2-NDEPA )
PMA (4-MA)
(e.g., TMA-3 , TMA-4 , TMA-5 )
TOMSO
ZDCM-04
1-Aminomethylindanes (e.g., 2CB-Ind , jimscaline )
2-Aminoindanes (e.g., DOM-AI )
3-Phenylpiperidines (e.g., LPH-5 , LPH-48 )
Benzazepines (e.g., lorcaserin )
Benzocyclobutenes (e.g., 2CBCB-NBOMe , TCB-2 , tomscaline )
Benzoxepins (e.g., BBOX , IBOX , TFMBOX )
DMBMPP (juncosamine)
Ergolines /lysergamides (e.g., LSD )
Glaucine
IHCH-7113
Partial ergolines (e.g., NDTDI , DEIMDHPCA , DEMPDHPCA , DEMTMPDHPCA , DEMNDHPCA )
Phenylcyclopropylamines (e.g., DMCPA , TMT )
Phenyloxazolamines (aminorexes ) (e.g., 2C-B-aminorex )
Z3517967757
ZC-B
Others
Arylpiperazines (e.g., 2C-B-PP , 2-NP , mCPP , MK-212 , ORG-12962 , pCPP , pFPP , quipazine , TFMPP )
Dihydrobenzoxazines (e.g., efavirenz )
Phenoxyethylamines (e.g., CT-4719 , ORG-37684 )
Quinazolinylethylamines (e.g., RH-34 )
Natural sources
Tryptamines: Acacia spp. (e.g., Acacia acuminata , Acacia confusa )
Ayahuasca and vinho de Jurema (e.g., Psychotria viridis (chacruna) , Dipolopterys cabrerana (chaliponga, chacruna) , Mimosa tenuiflora (Mimosa hostilis ; jurema) )
Brosimum (e.g., Brosimum acutifolium (takini) )
Hallucinogenic snuffs (e.g., Anadenanthera peregrina (yopo, jopo, cohoba, parica, ebene) , Anadenanthera colubrina (vilca, cebil) )
Incilius alvarius (Bufo alvarius ; Colorado River toad, Sonoran Desert toad; bufo)
Psilocybin-containing mushrooms (magic mushrooms, shrooms) (e.g., Psilocybe cubensis , Psilocybe mexicana (teonanacatl) )
Lysergamides: Achnatherum robustum (sleepy grass)
Epichloë spp.
Ergot (Claviceps ) (e.g., Claviceps purpurea , Claviceps paspali )
Morning glory (Convolvulaceae) seeds (e.g., Ipomoea tricolor (tlitliltzin, badoh negro; Ipomoea violacea ) , Ipomoea corymbosa (coaxihuitl, ololiúqui; Rivea Corymbosa , Turbina Corymbosa ) , Argyreia nervosa (Hawaiian baby woodrose; HBWR) )
Periglandula spp. (e.g., Periglandula ipomoeae , Periglandula clandestina )